151 - 200 of 8587 Results
Title
Year
-
RESTRICTEDTitle: Genetic Testing for Parkinson DiseaseJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 1Start Page: 69End Page: 77Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000831Best OA location URL: https://cp.neurology.org/content/neurclinpract/11/1/69.full.pdfCitation Count: 23
- Lewy Body Disorders2017RESTRICTEDTitle: Lewy Body DisordersJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 35Issue #: 2Start Page: 325End Page: 338Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2017.01.004Best OA location URL: https://europepmc.org/articles/pmc5912679?pdf=renderCitation Count: 50
- A More Homogeneous Phenotype in Parkinson's Disease Related to R1441G Mutation in the LRRK2 Gene2021RESTRICTEDTitle: A More Homogeneous Phenotype in Parkinson's Disease Related to R1441G Mutation in the LRRK2 GeneJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.635396Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.635396/pdfCitation Count: 12
-
RESTRICTEDTitle: Early Dyskinesias in Parkinson’s Disease Patients With Parkin Mutation: A Primary Corticostriatal Synaptopathy?Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2019.00273Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2019.00273/pdfCitation Count: 9
-
RESTRICTEDTitle: Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA SymposiumJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.805135Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.805135/pdfCitation Count: 15
-
RESTRICTEDTitle: Current Directions in Deep Brain Stimulation for Parkinson’s Disease—Directing Current to Maximize Clinical BenefitJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 25End Page: 41Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-020-00181-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-020-00181-9.pdfCitation Count: 35
-
RESTRICTEDTitle: Clinical Use of On-Demand Therapies for Patients with Parkinson’s Disease and OFF PeriodsJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 12Issue #: 4Start Page: 1033End Page: 1049Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-023-00486-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-023-00486-5.pdfCitation Count: 2
-
RESTRICTEDTitle: Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 202End Page: 209Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.08.001Best OA location URL: https://europepmc.org/articles/pmc6037988?pdf=renderCitation Count: 74
-
RESTRICTEDTitle: Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 236End Page: 245Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.expneurol.2017.07.019Best OA location URL: https://doi.org/10.1016/j.expneurol.2017.07.019Citation Count: 128
-
RESTRICTEDTitle: Therapeutic approaches to target alpha-synuclein pathologyJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 225End Page: 235Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.expneurol.2017.10.003Best OA location URL: http://manuscript.elsevier.com/S0014488617302455/pdf/S0014488617302455.pdfCitation Count: 192
-
RESTRICTEDTitle: A comprehensive review of the diagnosis and treatment of Parkinson’s disease dysphagia and aspirationJournal Name: Expert Review of Gastroenterology & HepatologyPublisher: Informa UK LimitedVol: 14Issue #: 6Start Page: 411End Page: 424Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/17474124.2020.1769475Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405619Citation Count: 24
-
RESTRICTEDTitle: Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.00097Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.00097/pdfCitation Count: 67
-
RESTRICTEDTitle: Ten Unsolved Questions About Neuroinflammation in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 16End Page: 24Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28075Best OA location URL: https://inserm.hal.science/inserm-02568209/file/ReviewMDSinflammationRev11%20dgs%20eh.pdfCitation Count: 142
-
OPENTitle: 3D convolutional neural networks for classification of Alzheimer’s and Parkinson’s disease with T1-weighted brain MRIJournal Name: 17th International Symposium on Medical Information Processing and AnalysisPublisher: SPIEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1117/12.2606297Best OA location URL: https://doi.org/10.1101/2021.07.26.453903Citation Count: 1
-
RESTRICTEDTitle: Linking neuroscience with modern concepts of impulse control disorders in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 2Start Page: 141End Page: 149Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26068Best OA location URL: https://europepmc.org/articles/pmc4318759?pdf=renderCitation Count: 79
-
RESTRICTEDTitle: Vascular Parkinsonism: Deconstructing a SyndromeJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 886End Page: 894Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26263Best OA location URL: https://europepmc.org/articles/pmc4478160?pdf=renderCitation Count: 87
-
RESTRICTEDTitle: LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectivesJournal Name: Clinical Pharmacology: Advances and ApplicationsPublisher: Informa UK LimitedVol: Volume 8Issue #:Start Page: 177End Page: 189Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/cpaa.s102191Best OA location URL: https://www.dovepress.com/getfile.php?fileID=33080Citation Count: 41
-
RESTRICTEDTitle: Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairmentJournal Name: Human Brain MappingPublisher: WileyVol: 40Issue #: 18Start Page: 5424End Page: 5442Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/hbm.24782Best OA location URL: https://europepmc.org/articles/pmc6864887?pdf=renderCitation Count: 130
-
RESTRICTEDTitle: Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies – a mini reviewJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 32Issue #: 4Start Page: 291End Page: 297Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10286-022-00882-1Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101699Citation Count: 5
-
RESTRICTEDTitle: LRRK2 mutations and neurotoxicant susceptibilityJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 240Issue #: 6Start Page: 752End Page: 759Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1535370215579162Best OA location URL: https://europepmc.org/articles/pmc4935210?pdf=renderCitation Count: 28
-
RESTRICTEDTitle: At the dawn of the transcriptomic medicineJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 246Issue #: 3Start Page: 286End Page: 292Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1535370220954788Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876640Citation Count: 7
-
RESTRICTEDTitle: Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson’s diseaseJournal Name: Experimental & Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 47Issue #: 8Start Page: e179End Page: e179Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/emm.2015.54Best OA location URL: https://www.nature.com/articles/emm201554.pdfCitation Count: 27
-
RESTRICTEDTitle: Mitochondrial isolation: when size mattersJournal Name: Wellcome Open ResearchPublisher: F1000 Research LtdVol: 5Issue #:Start Page: 226End Page: 226Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.12688/wellcomeopenres.16300.2Best OA location URL: https://wellcomeopenresearch.org/articles/5-226/v2/pdfCitation Count: 4
-
RESTRICTEDTitle: Intracellular Thermometry at the Micro‐/Nanoscale and its Potential Application to Study Protein Aggregation Related to Neurodegenerative DiseasesJournal Name: ChemBioChemPublisher: WileyVol: 22Issue #: 9Start Page: 1546End Page: 1558Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/cbic.202000765Citation Count: 9
-
RESTRICTEDTitle: Recent Advances in the Development of Stem‐Cell‐Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1772End Page: 1780Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28628Citation Count: 34
-
RESTRICTEDTitle: Synaptic tau: A pathological or physiological phenomenon?Journal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01246-yBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-021-01246-yCitation Count: 39
-
RESTRICTEDTitle: How to proceed after “negative” exome: A review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniquesJournal Name: Journal of Inherited Metabolic DiseasePublisher: WileyVol: 45Issue #: 4Start Page: 663End Page: 681Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/jimd.12507Best OA location URL: https://repository.ubn.ru.nl/bitstream/handle/2066/282561/1/282561.pdfCitation Count: 20
-
RESTRICTEDTitle: GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 5Start Page: 1859End Page: 1872Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac413Best OA location URL: https://academic.oup.com/brain/article-pdf/146/5/1859/50127735/awac413.pdfCitation Count: 11
-
RESTRICTEDTitle: Risk of Chronic Cardiomyopathy Among Patients With the Acute Phase or Indeterminate Form of Chagas DiseaseJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 3Issue #: 8Start Page: e2015072End Page: e2015072Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2020.15072Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2770045/chadalawada_2020_oi_200567_1602703565.56257.pdfCitation Count: 50
-
RESTRICTEDTitle: LRRK2 Phosphorylation, More Than an EpiphenomenonJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00527Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00527/pdfCitation Count: 41
-
RESTRICTEDTitle: Clinical implications of gastric complications on levodopa treatment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 76Issue #:Start Page: 63End Page: 71Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.001Best OA location URL: http://www.prd-journal.com/article/S1353802020301103/pdfCitation Count: 42
-
RESTRICTEDTitle: Excitotoxicity Revisited: Mitochondria on the Verge of a Nervous BreakdownJournal Name: Trends in NeurosciencesPublisher: Elsevier BVVol: 44Issue #: 5Start Page: 342End Page: 351Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.tins.2021.01.001Best OA location URL: https://discovery.ucl.ac.uk/10122786/9/Duchen_071220_Plotegher%20et%20al._final.pdfCitation Count: 28
-
RESTRICTEDTitle: The Evolution-Driven Signature of Parkinson’s DiseaseJournal Name: Trends in NeurosciencesPublisher: Elsevier BVVol: 43Issue #: 7Start Page: 475End Page: 492Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.tins.2020.05.001Best OA location URL: https://doi.org/10.1016/j.tins.2020.05.001Citation Count: 23
-
RESTRICTEDTitle: Multidisciplinary Care to Optimize Functional Mobility in Parkinson DiseaseJournal Name: Clinics in Geriatric MedicinePublisher: Elsevier BVVol: 36Issue #: 1Start Page: 159End Page: 172Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cger.2019.09.008Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/214080/214080.pdfCitation Count: 19
-
RESTRICTEDTitle: BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancerJournal Name: Lung CancerPublisher: Elsevier BVVol: 146Issue #:Start Page: 78End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.lungcan.2020.05.018Citation Count: 25
-
RESTRICTEDTitle: Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global reviewJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 11Start Page: 3947End Page: 3960Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10588-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10588-5.pdfCitation Count: 28
- Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments2021RESTRICTEDTitle: Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New TreatmentsJournal Name: Archives of Medical ResearchPublisher: Elsevier BVVol: 52Issue #: 3Start Page: 243End Page: 251Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arcmed.2020.10.021Citation Count: 25
-
RESTRICTEDTitle: Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and DevelopmentJournal Name: Therapeutic Innovation & Regulatory SciencePublisher: Springer Science and Business Media LLCVol: 54Issue #: 1Start Page: 103End Page: 116Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s43441-019-00034-0Citation Count: 27
-
RESTRICTEDTitle: Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine eraJournal Name: Medicinal Research ReviewsPublisher: WileyVol: 40Issue #: 6Start Page: 2650End Page: 2681Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/med.21718Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/med.21718Citation Count: 33
-
RESTRICTEDTitle: Upstream deregulation of calcium signaling in Parkinson’s diseaseJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2014.00053Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2014.00053/pdfCitation Count: 20
-
RESTRICTEDTitle: Parkinson’s disease-implicated kinases in the brain; insights into disease pathogenesisJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2014.00057Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2014.00057/pdfCitation Count: 67
-
RESTRICTEDTitle: Targeting Alpha-Synuclein as a Therapy for Parkinson’s DiseaseJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2019.00299Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2019.00299/pdfCitation Count: 217
-
RESTRICTEDTitle: New Developments in Genetic rat models of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 5Start Page: 717End Page: 729Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27296Best OA location URL: https://europepmc.org/articles/pmc5992003?pdf=renderCitation Count: 70
-
RESTRICTEDTitle: CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and ChallengesJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2020.00038Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2020.00038/pdfCitation Count: 154
-
RESTRICTEDTitle: Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathiesJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 3Start Page: 372End Page: 390Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27344Best OA location URL: https://europepmc.org/articles/pmc5844369?pdf=renderCitation Count: 162
-
RESTRICTEDTitle: From reinforcement learning models to psychiatric and neurological disordersJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 14Issue #: 2Start Page: 154End Page: 162Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nn.2723Best OA location URL: https://europepmc.org/articles/pmc4408000?pdf=renderCitation Count: 648
-
RESTRICTEDTitle: Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?Journal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 7Start Page: 955End Page: 971Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27038Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27038Citation Count: 179
-
RESTRICTEDTitle: Which ante mortem clinical features predict progressive supranuclear palsy pathology?Journal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 7Start Page: 995End Page: 1005Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27034Best OA location URL: https://europepmc.org/articles/pmc5543934?pdf=renderCitation Count: 127
-
RESTRICTEDTitle: The Neuroprotective Role of Protein Quality Control in Halting the Development of Alpha-Synuclein PathologyJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2017.00311Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2017.00311/pdfCitation Count: 16
-
RESTRICTEDTitle: Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literatureJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 11Start Page: 1504End Page: 1523Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27193Best OA location URL: https://europepmc.org/articles/pmc5726430?pdf=renderCitation Count: 237